Cell-line study reports epitalon lengthens telomeres via hTERT and ALT pathways
Brunel University London and Royal Brompton researchers saw dose-dependent telomere gains in normal cells, but also telomere lengthening in breast cancer lines.
PR
By Priya Raman · Science Reporter
Sep 29 02:25 ETSource: FinancialContent
The wire
- 01A Biogerontology paper tested epitalon in normal epithelial cells, fibroblasts and breast cancer cell lines, reporting dose-dependent telomere-length increases with higher hTERT expression and telomerase activity.
- 02Epitalon is widely sold in the gray market on longevity claims, and this is mechanistic laboratory data that clinicians will be asked about by patients.
- 03These were human cell-line experiments only, and the announcement itself notes they do not show epitalon extends lifespan or reverses aging in people; telomere lengthening in cancer lines via the ALT pathway warrants caution. The item was distributed as a newswire press release.
From the source
Read at financialcontent.comEpitalon Peptide Research Brings Renewed Attention to Telomeres and Cellular Aging
CHICAGO, IL / ACCESS Newswire / September 29, 2026 / Recent research examining the effects of Epitalon peptide on telomere-maintenance mechanisms has renewed attention to the peptide as scientists investigate cellular aging and healthspan amid a rapidly aging global population.
